What is the H3N2 Virus? H3N2 is a subtype of the Influenza A virus that causes seasonal flu outbreaks, particularly in cold or post-monsoon months. It spreads easily through respiratory droplets and is known for causing more severe illness in the elderly, children, and those with weak immunity. Why Is H3N2 Making News in 2025? […]
Blog
Brain-Eating Amoeba in Kerala: Sixth Death Reported in a Month – What You Need to Know
Kerala is currently facing a health scare after reporting six deaths due to amoebic meningoencephalitis, a rare but fatal brain infection caused by the so-called brain-eating amoeba, Naegleria fowleri. The alarming rise in cases has raised concerns across the state, especially in districts such as Kozhikode, Malappuram, and Alappuzha. At DNA Labs India, we believe […]
AI Stethoscope for Early Detection of Heart Failure, Atrial Fibrillation, and Heart Valve Disease
The new AI-powered stethoscope is transforming heart disease diagnosis by combining ECG monitoring and advanced audio analysis with instantaneous cloud-based AI assessment, enabling the rapid detection of three major heart conditions—heart failure, atrial fibrillation, and heart valve disease—in just 15 seconds. This innovation addresses a long-standing healthcare challenge: most heart failure cases are only diagnosed […]
MyClimb Study: 93% Pediatric MYBPC3‑HCM Is Nonobstructive
Tenaya’s interim MyClimb data suggest 93% of children with MYBPC3-associated HCM have the nonobstructive form with no approved therapies today, highlighting an urgent need for disease-modifying options and better risk stratification. ✨ What’s new 🧬 Genetics that shape outcomes 📈 Biomarker signal: LVMI 🧒 Clinical gap in pediatrics 🧪 Pipeline context: TN‑201 gene therapy ❓ […]
Visceral Fat, Not Pressure: How Adipokines May Drive HFpEF
Heart failure with preserved ejection fraction may be driven primarily by dysfunctional visceral fat and harmful adipokines—shifting screening toward waist‑to‑height ratio and treatment toward fat‑targeting therapies, including GLP‑1 agents. ✨ What’s new 🧠 Fat biology over pressure 🧍 Who’s at risk (beyond BMI) 💊 Treatment implications 📏 How to measure (simple and scalable) 🧪 Why […]
IVF Efficiency After 35: Prioritizing Euploid Embryos with PGT-A
Genetic testing of IVF embryos can help women aged 35–42 conceive in fewer transfers and may raise cumulative live birth rates, easing the emotional burden of repeated cycles in advanced maternal age. ✨ What’s new 🧪 Trial design and outcomes 🧠 Why this matters after 35 👥 Who may benefit most 💰 Costs, access, and […]
Universal mRNA Cancer Vaccine Eliminates Tumors in Mice
✨ What’s New University of Florida scientists developed an experimental mRNA cancer vaccine that eliminated tumors in mouse models of melanoma, bone cancer, and brain cancer by activating broad type‑I interferon–driven immunity rather than targeting specific tumor antigens. 🧪 How This Vaccine Differs 🚀 Why It Matters 🧫 Key Preclinical Findings (Mice) 🔎 Context and […]
Growing the First Heart and Brain Organoids in Space: A New Frontier for Medicine
🛰️ Mission Overview A team led by Cedars-Sinai Medical Center is sending stem cells to the International Space Station to create the first heart and brain organoids grown in space. The launch is scheduled for 2:45 a.m. EDT Sunday on NASA’s 33rd commercial resupply mission. By leveraging microgravity, researchers aim to overcome Earth-bound limitations in […]
Oxford Scientists Crack a 50‑Year Metabolomics Challenge
🚀 What’s New A team from Oxford University’s Department of Chemistry (McCullagh Group) has unveiled a metabolomics protocol that overcomes a decades‑old bottleneck: directly coupling anion‑exchange chromatography (AEC) to mass spectrometry (MS). By integrating electrolytic ion‑suppression after chromatographic separation, the method enables sensitive detection of highly polar and ionic metabolites that drive primary cellular pathways—long […]
Cancer Cells Hijack Nerves to Evade Immunotherapy: A New Tumor–Neuro–Immune Axis
Nature study shows cancer-induced nerve injury drives resistance to anti-PD-1 therapy; IL-6/IFN pathways emerge as actionable targets. 🧠 What’s New A multi-institutional team led by Moffitt Cancer Center, Karolinska Institutet, and MD Anderson has uncovered a previously unknown mechanism by which cancers co-opt the nervous system to resist immunotherapy. Published today in Nature, the study […]